The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
here is the whole file if interested by the way
https://oeilm.secure.europarl.europa.eu/oeil-mobile/fiche-procedure/2018/0145(COD)
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&reference=IMCO-OJ-20190220-1&language=EN
Been public for a while by the way and not that hard to find, but having DMS becoming mandatory for all vehicles and having them review camera based DMS by 2021 is already more than we could wish for. Euro NCAP is hopefully the one making this investment an absolute blowout
Personally, have everything in leveraged IG accounts but agree that the leverage you get is not great. Nevertheless, including tax benefits the upside is still worth it. Also use to have loads of small positions with guaranteed stop-losses but have changed those to cash leveraged positions given the volatility (the double counting of losses also annoyed me). P&L looks pretty ugly today but not too worried, industry backdrop is positive and no one seems to take market of us.
By the way doing the same, retail investor as the reduction in margin is limited and like my downside protection here.
Does anyone know whay technical qualification really means here? Is this simply testing which they could with multiple suppliers at the time, or did you win the bid with Veoneer and you are working with OEM to a final product?
http://www.europarl.europa.eu/RegData/etudes/BRIE/2018/625192/EPRS_BRI(2018)625192_EN.pdf
Interesting summary with stakeholder views, all supportive
Not a bad moment for Jack to buy some shares and give us some comfort here. Personally think it’s shameful how you throw out an RNS highlighting that Paul got 11m shares when you already know things are looking pretty badly Really hope large institutional investors will make them sweat
seeingtom that is why they are relying mainly now on distributors, who do all the work but take a decent share of revenues (40%). Will be much quicker way of growth than doing it themselves. Not too worried there personally
From the RNS on 21st of May "The Fleet business has very strong momentum, with an installed base of 10,000 units". He is simply not giving any updated numbers. They added 7000 from July-17 to May-18, so using same rate they should be at 12,000 already. However that is probably way too low given momentum now with Gen-2
For me key point is getting to positive cash flows asap, selling units will be the main driver of that. Agree lag of installing not great but they will at some point, on of the things company changed recently is adding incentives for companies to do it quicker
Confused by that one too, but main driver of results will be units sold. If you run probability adjusted pipeline analysis then selling 40,000 units seems to be very achievable if not way too low. Then they are trailing with insurance companies around the world including Asia and the US for fleet customers to get 10-15% discounts which should be a massive boost if finalised. Think today we just have Zurich in NZ On connected units, they added more than 7000 from Jun-17 to May-18 so something has to be really bad if Ken meant only 10,000 to be added for the full year now. It must be something else
Haha I like your thinking! Lets see, hopefully 2019 projections will be better than we thought. Did some analysis on the Cenkos pipeline of A$295m in March, assuming average revenue per guardian contract to SEE is around A$2,500 (based on geographical split and % distributors) that gets you to quiet a bit more than the projected 40,000 devices based on a probability adjusted pipeline. Just a bit of a mystery why the company is not sharing details of progression in fleet besides "very strong momentum", 300 customer etc.